DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
SCDAA National SCD Policy Forum
REGISTER TODAY!
The Sickle Cell Disease Association of America, Inc. is proud to present the first-ever National SCD Policy Forum on March 21 & 22, 2023. This tri-collaborative event is hosted by SCDAA, Sick Cells (@sickcells), and the Sickle Cell Community Consortium (@sccconsortium). Our three organizations are working hard to host the most comprehensive advocacy event for sickle cell disease (SCD) to date.
The goal of this event is to:
• Bring together SCD advocates from across the country.
• Build awareness of federal opportunities for SCD.
• Educate legislators on funding and policy interventions that support the needs of SCD Warriors and the SCD community as a whole.
Day 1 will be full of trainings on the 2023 federal priorities for SCD.
Day 2 is our virtual Hill Day, a time for advocates to connect directly with their federal legislators.
+myBinderRelated Content
-
Community CenterKyriako Damavoletes Talks About the Stigma of Sickle Cell DiseaseKyriako Damavoletes has HbS beta thalass...
-
education & researchA Validated Measure of Adherence to Antibiotic Prophylaxis in Children With Sickle Cell DiseaseAntibiotic prophylaxis is a mainstay in ...
-
education & researchDexmedetomidine as an adjuvant to analgesic strategy during vaso-occlusive episodes in adolescents with sickle cell ...Sickle cell disease (SCD)-patients exper...
-
news & eventsSickle Cell Patient Receives CRISPR Gene TherapyMany human diseases can be traced back t...
-
news & eventsTown Hall Meeting: A policy discussion on the challenges facing the sickle cell communityHemoglobinopathies (Sickle Cell ...
-
people & placesRobert H. Broyles, PhDRobert H. Broyles was founder and presid...
-
news & eventsMARAC Advisory Statement: Update About COVID-19December 23, 2021 – The Sickle Cell Di...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.